Lifeway Foods, Inc. (LWAY) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly report (Form 10-Q) for Lifeway Foods, Inc. for the period ended June 30, 2026. Lifeway is the largest producer and marketer of kefir in the U.S., operating as a single reportable segment focused on cultured dairy products. The company is classified as a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | Q2 2025 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Net Sales | $66.9 million | $53.9 million | $129.9 million | $100.0 million |
| Gross Profit | $13.0 million | $15.4 million | $30.4 million | $26.4 million |
| Gross Margin | 19.5% | 28.6% | 23.4% | 26.5% |
| Operating Income | $0.6 million | $5.8 million | $6.9 million | $7.4 million |
| Net Income | $0.1 million | $4.2 million | $4.8 million | $7.8 million |
| Diluted EPS | $0.01 | $0.28 | $0.31 | $0.51 |
| Cash & Equivalents | $7.1 million (as of June 30, 2026) | |||
| Operating Cash Flow (YTD) | $4.0 million | |||
| Debt (Line of Credit) | $22.0 million outstanding; $3.0 million available |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 24.1% in Q2 and 29.9% YTD compared to 2025, driven primarily by higher volumes of branded drinkable kefir.
- Margin Compression: Gross margins declined significantly (from 28.6% to 19.5% in Q2) due to unfavorable pricing for conventional milk, resin-based packaging inputs, and transportation costs.
- Profitability Decline: Net income dropped 97% in Q2 and 38% YTD. The Q2 decline was exacerbated by a high effective tax rate (68.7%) due to low pre-tax income and non-deductible items, compared to 28.1% in the prior year.
- Capital Expenditures: Investing cash outflows surged to $19.3 million YTD (vs. $0.8 million inflow in 2025) due to a major expansion and modernization project at the Waukesha, WI facility.
- Shareholder Activity: The company repurchased 253,153 shares for $4.9 million in May 2026 during a public offering by a selling stockholder (Danone USA). The company also redeemed its Shareholder Rights Plan in June 2026.
Outlook, Risks, and Management Commentary
- Cost Environment: Management anticipates elevated milk and packaging costs to continue into Q3 2026 before potentially decreasing in Q4. Tariffs are not currently expected to have a material adverse impact as the company sources and sells primarily within the U.S.
- Capital Projects: The Waukesha facility expansion, estimated at $50.5 million total, aims to double manufacturing capacity. The project is expected to be completed in Q1 2027, with increased scale manufacturing beginning in January 2027.
- Liquidity: The company maintains a strong liquidity position with $7.1 million in cash, $3.0 million available on its revolving credit facility, and a new $22.0 million Interim Funding Agreement for equipment financing.
- Risks: Key risks include commodity price volatility (milk, oil/packaging), supply chain disruptions, and the ability to successfully implement growth strategies. The company is currently in compliance with all debt covenants.
Investor Verification Checklist
- Verify the sustainability of the 24% revenue growth rate against the backdrop of rising input costs.
- Monitor the trajectory of gross margins in Q3 and Q4 to assess if cost inflation is being passed through to consumers.
- Review the timeline and budget adherence for the $50.5 million Waukesha facility expansion.
- Assess the impact of the high effective tax rate in Q2 on future earnings per share projections.
- Confirm the utilization of the new $22 million Interim Funding Agreement for the capital expansion.